VCA
Vascular Centers of America is a private multi-site healthcare provider founded in 2016 that treats Peripheral Artery Disease through diagnostics, medication, exercise therapy, compression stockings, and minimally invasive vascular procedures across five metropolitan areas in Michigan, New York, Arizona, and Illinois.
- Company typePrivate
- Founded2016
- HeadquartersSouthfield, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What VCA does
Vascular Centers of America (VCA) is a private, multi-site healthcare provider founded in 2016 and headquartered in Southfield, Michigan, that specializes in the diagnosis and treatment of Peripheral Artery Disease (PAD) and related vascular conditions. The company delivers care through owned clinic locations across five metropolitan areas in four states — Southfield, MI; Manhattan, NY; Phoenix, AZ; Scottsdale, AZ (Procedure Center); and Chicago, IL — with a sixth site in Brooklyn, NY announced as coming soon. Services span the full PAD care continuum: diagnostic testing (ABI, CT Angiogram, Doppler/Duplex Ultrasound, MRA), pharmacological management, supervised exercise/PT programs, compression stockings, and minimally invasive procedures including angioplasty, atherectomy, and stent placement. The underlying clinical technology is conventional endovascular medicine rather than any proprietary platform; VCA holds no disclosed patents, trademarks, APIs, AI/ML capabilities, or technology integrations.
The business model is direct-to-patient fee-for-service. VCA publicly lists unit pricing for entry-level services ($29 medication, $49 structured exercise/PT, $99 compression stockings), while complex procedures are quote-based following consultation. Patient acquisition is sales-led through phone and web-form consultation bookings, supported by a multi-channel marketing mix including YouTube, LinkedIn, Facebook, educational website content, earned media on local news affiliates (WDIV, WXYZ), and regional recognition via the 2026 Detroit Community Choice Awards. The customer base is individual PAD patients (primary) and at-risk individuals aged 50+ with cardiovascular risk factors such as diabetes, hypertension, and smoking history (secondary), segmented horizontally by use case rather than by enterprise contract.
The company is privately held with no disclosed funding rounds, institutional investors, parent company, or M&A activity. Workforce size is 101-250 employees distributed across the six locations. No certifications, regulatory actions, or formal management team data were disclosed in source material, representing transparency gaps relative to a typical investment-ready profile.
VCA firmographics
Firmographics- Name
- VCA
- Legal name
- Vascular Centers of America
- Website
- https://vascularcentersofamerica.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Vascular Centers of America is a private multi-site healthcare provider founded in 2016 that treats Peripheral Artery Disease through diagnostics, medication, exercise therapy, compression stockings, and minimally invasive vascular procedures across five metropolitan areas in Michigan, New York, Arizona, and Illinois.
- Ownership category
- akta.pro rank
VCA industry classification
Industry- Product category
- Vascular Care Services
- NAICS
- Offices of Physicians (62111), Ambulatory Health Care Services (621)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Vascular Medicine (Peripheral Arterial/Venous Disease) (HLAKABAG)
- akta.pro secondary industry
- Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK)
Keywords
Where VCA is headquartered
LocationHeadquarters
- HQ city
- Southfield
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
VCA business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Medical Treatment Services: VCA generates revenue through per-person medical treatment fees for PAD and PVD conditions. Services are priced individually: medication at $29 per person, structured walking/exercise/PT programs at $49 per person, and compression stockings at $99 per person. Additional revenue comes from diagnostic procedures and minimally invasive treatments (angioplasty, atherectomy, stent placement) which are quoted individually based on patient needs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Medication - $29 per person |
| Unit Pricing | Pay-as-you-go | Structured walking/Exercise/PT programs - $49 per person |
| Unit Pricing | Pay-as-you-go | Compression stockings - $99 per person |
| Other | Pay-as-you-go | Minimal Procedure (angioplasty, atherectomy, stent placement) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
VCA product offering
Product offeringCore offering
Vascular Centers of America is a physician-led healthcare provider that diagnoses and treats peripheral artery disease (PAD) and peripheral vascular disease (PVD) at owned clinic locations. The company offers a complete PAD care pathway including diagnostic testing (ABI test, CT Angiogram, Doppler/Duplex Ultrasound, MRA), medication management, structured walking/exercise/physical therapy programs, compression stockings, and minimally invasive procedures (angioplasty, atherectomy, stent placement). Services are priced individually and delivered in-person to patients seeking to restore leg circulation, prevent limb loss, and reduce cardiovascular risk.
Product overview
Vascular Centers of America (VCA) is a healthcare provider offering a unified suite of peripheral artery disease (PAD) treatment services. Established in 2016, the company provides diagnostic testing, medication management, structured exercise/physical therapy programs, compression stockings, and minimally invasive procedures (angioplasty, atherectomy, stent placement). The services are delivered at multiple treatment centers across five cities (Southfield MI, Manhattan NY, Phoenix AZ, Scottsdale AZ, Chicago IL) with Brooklyn NY opening soon. The company focuses on preventing limb loss through comprehensive PAD care, with pricing starting at $29 for medication, $49 for exercise programs, and $99 for compression stockings.
Differentiator
Problem solved
Functional benefit
Products and services
- PAD Care Services Comprehensive medical treatment program for Peripheral Artery Disease (PAD), including diagnosis, treatment planning, and ongoing care to improve blood flow and prevent limb loss, delivered by physician-led clinical teams at VCA treatment centers.
- Medication Management Pharmacological treatment priced at $29 per person that reduces blood pressure and cholesterol, prevents blood clots, improves blood flow, and alleviates PAD symptoms such as pain and cramping.
- Structured Walking / Exercise / PT Programs Supervised exercise therapy priced at $49 per person designed to improve circulation, strengthen muscles, and increase mobility while reducing PAD symptoms.
- Compression Stockings Medical compression garments priced at $99 per person that improve blood flow by applying gentle pressure, reduce swelling and discomfort, and help prevent blood clots; requires provider evaluation prior to use.
- Minimal Procedure (Angioplasty, Atherectomy, Stent Placement) Minimally invasive vascular procedures that restore blood flow through angioplasty, atherectomy, or stent placement to reduce plaque in arteries, offer long-term relief, and prevent complications; pricing is quote-based and requires consultation.
- PAD Diagnostic Testing Diagnostic services including medical history review, physical exam, ABI (Ankle-Brachial Index) test, CT Angiogram, regular angiogram, Doppler and Duplex Ultrasound Imaging, and Magnetic Resonance Angiogram (MRA) used to identify and stage peripheral artery disease.
Companies that use VCA
Customer profileSegments2 records
Ideal customer profiles2 records
VCA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
VCA partnerships and signals
Strategic signalScale indicators3 records
Recent moves7 records
Expansion highlights5 records
VCA competitors and assessment
Company assessmentBroad incumbents
- Cleveland Clinic: Top-tier U.S. health system with a large Heart, Vascular & Thoracic Institute performing PAD diagnostics and interventions at scale; represents the hospital-system incumbent that VCA competes against for referrals and patients.
- HCA Healthcare: Largest for-profit hospital operator in the U.S. with extensive vascular surgery and cardiology service lines across hundreds of facilities; a broad incumbent competitor for PAD patients and physician talent.
- Surgery Partners: Operator of short-stay surgical facilities including ambulatory surgery centers where vascular and interventional procedures are performed; adjacent business model to VCA's procedure center in Scottsdale.
- Tenet Healthcare: Diversified healthcare operator running hospitals and a large USPI ambulatory surgery network that performs vascular interventions; represents a broad incumbent competing for outpatient vascular procedures.
Direct peers
- The Vascular Care Group: Multi-site specialty vascular medicine practice providing diagnostic and interventional vascular services in an outpatient setting, structurally analogous to VCA's physician-led clinic model.
- Vein Clinics of America: Historic physician-led outpatient chain offering minimally invasive treatment of vein and vascular disease; comparable to VCA in service scope and patient demographic, though currently in a state of corporate transition.
- USA Vein Clinics: National specialty clinic chain focused on vein and vascular disease treatment with multiple outpatient locations, directly comparable to VCA's multi-state specialty vascular clinic model and patient demographic.
- Center for Vein Restoration: One of the largest physician-led vein and vascular clinic networks in the U.S., offering diagnosis and minimally invasive treatment of venous and arterial disease in a similar outpatient clinic setting to VCA.
Others
- Boston Scientific: Major peripheral intervention device manufacturer producing drug-eluting stents, atherectomy systems, and specialty balloons; supplies the equipment underpinning the minimally invasive procedures that VCA delivers.
- Medtronic: Leading manufacturer of peripheral vascular intervention devices including stents, atherectomy catheters, and angioplasty balloons used in procedures like those VCA performs; a key supplier rather than direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
VCA social profiles
Digital presenceVCA financial estimates
Financial estimateRevenue estimate
Valuation estimate
VCA leadership team
Management profileNumber of profiles
VCA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VCA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VCA
What does VCA do?
Vascular Centers of America is a physician-led healthcare provider that diagnoses and treats peripheral artery disease (PAD) and peripheral vascular disease (PVD) at owned clinic locations. The company offers a complete PAD care pathway including diagnostic testing (ABI test, CT Angiogram, Doppler/Duplex Ultrasound, MRA), medication management, structured walking/exercise/physical therapy programs, compression stockings, and minimally invasive procedures (angioplasty, atherectomy, stent placement). Services are priced individually and delivered in-person to patients seeking to restore leg circulation, prevent limb loss, and reduce cardiovascular risk.
Is VCA a public or private company?
VCA is a private company. It is classified as unknown and is currently operating.
When was VCA founded?
VCA was founded in 2016. It employs 101 to 250 people.
Where is VCA based?
VCA is headquartered in Southfield, United States, in the North America region.
How does VCA make money?
One revenue line is on record: medical Treatment Services.
Who are VCA's main competitors?
Broad incumbents on record are Cleveland Clinic, HCA Healthcare, Surgery Partners and Tenet Healthcare. Direct peers are The Vascular Care Group, Vein Clinics of America, USA Vein Clinics and Center for Vein Restoration. Others are Boston Scientific and Medtronic.
Does VCA have an API?
No public API is recorded for VCA.
What industry is VCA in?
VCA's product category is Vascular Care Services. Its primary akta.pro industry code is HLAKABAG, Vascular Medicine (Peripheral Arterial/Venous Disease), with a secondary code of HLAFABAK, Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based). Its NAICS code is 62111 and its SIC code is 8093.